Market Tracker

10/24 12:54pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

92.79
Real-Time Quote
 +0.98 / +1.07%
Today’s Change
47.03
Today|||52-Week Range
112.57
+44.31%
Year-to-Date

Today’s Trading

Previous close91.81
Today’s open91.74
Day’s range91.08 - 94.99
Volume344,004
Average volume (3 months)706,578
Market cap$7.0B
Dividend yield--
Data as of 12:38pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-268.14%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book21.65

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.97+1.71%
CBSTCubist Pharmaceutica...-0.92-1.27%
ISISIsis Pharmaceuticals...+1.69+3.99%
ICLRICON PLC+0.17+0.30%
Data as of 12:53pm ET, 10/24/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts